Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality (original) (raw)

Abstract

Doxorubicin is an anticancer agent widely used in the treatment of human cancer. The major limitation of this drug governing the cell-killing effect appears to be its poor penetration into a tumor mass. We have studied the effects of hyaluronidase on the penetration and cell-killing effect of doxorubicin using multicellular tumor spheroids (MTS). MTS approximately 500 μm in diameter were produced by a liquid-overlay culture technique from PC-10 lung and HEp-2 laryngeal squamous carcinoma cell lines. Cells in MTS and monolayer were exposed to hyaluronidase for various lengths of time; this was followed by a 1-h resting interval and a subsequent 1-h exposure to doxorubicin. MTS and monolayer cells were then trypsinized to a single-cell suspension and subjected to clonogenic assay. Hyaluronidase at a concentration of 25 U/ml or 250 U/ml was nontoxic to the monolayer cells. For PC-10 MTS, pretreatment with 25 U/ml hyaluronidase for 24 h and 72 h resulted in approximately 20% increases in Doxorubicin cell killing at the median (IC50) dose as compared to doxorubicin alone. HEp-2 MTS were more sensitive to the hyaluronidase pretreatment. Thus, a 1-h exposure to the enzyme produced a 40% increase in doxorubicin-induced cell death at the IC50 dose. A fluorescence microscopic study revealed that a 1-h exposure of MTS to doxorubicin produced doxorubicin fluorescence only in the one or two outer layers of MTS. When MTS were pretreated with hyaluronidase, there was enhanced penetration of doxorubicin fluorescence into the MTS core. Hyaluronidase-induced enhancement of Doxorubicin penetration and its cell-killing effect is dependent on the exposure time and tumor cell origin. These data suggest that anecdotal reports of hyaluronidase-enhanced activity of preclinical chemotherapy deserve a controlled trial.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

MTS:

multicellular tumor spheroids

References

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113, Tokyo, Japan
    Naoyuki Kohno
  2. Department of Neoplastic Disease, Mount Sinai School of Medicine, New York, USA
    Takao Ohnuma
  3. St.-Johanns-Vorstadt 38, 4056, Basel, Switzerland
    Peter Truog

Authors

  1. Naoyuki Kohno
    You can also search for this author inPubMed Google Scholar
  2. Takao Ohnuma
    You can also search for this author inPubMed Google Scholar
  3. Peter Truog
    You can also search for this author inPubMed Google Scholar

Additional information

This work was supported in part by the Chemotherapy Foundation, Inc., New York, NY; by the T. J. Martell Foundation for Leukemia and Cancer Research, New York, NY and by the Hayashibara Biochemical Laboratories, Inc., Okayama, Japan

Rights and permissions

About this article

Cite this article

Kohno, N., Ohnuma, T. & Truog, P. Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality.J Cancer Res Clin Oncol 120, 293–297 (1994). https://doi.org/10.1007/BF01236386

Download citation

Key words